These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1647961)

  • 1. The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
    Trampus M; Ongini E; Varani K; Borea PA
    Eur J Pharmacol; 1991 Feb; 194(1):17-23. PubMed ID: 1647961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E; Alberch J; Marsal J
    Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study.
    Waksman G; Hamel E; Delay-Goyet P; Roques BP
    Brain Res; 1987 Dec; 436(2):205-16. PubMed ID: 2829989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of mu-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor.
    Bousselmame R; Michael-Titus A; Costentin J
    Eur J Pharmacol; 1991 Oct; 203(2):295-7. PubMed ID: 1666049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
    Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
    Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on mu- and delta-opioid binding sites: comparison with chronic morphine and chronic kelatorphan.
    Delay-Goyet P; Zajac JM; Roques BP
    Neurosci Lett; 1989 Aug; 103(2):197-202. PubMed ID: 2549472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.
    Stiene-Martin A; Hauser KF
    J Neurosci Res; 1991 Aug; 29(4):538-48. PubMed ID: 1665190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
    Unterwald EM; Cuntapay M
    Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
    Kavaliers M; Innes DG
    Pharmacol Biochem Behav; 1993 Dec; 46(4):777-80. PubMed ID: 8309954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
    Knapp RJ; Sharma SD; Toth G; Duong MT; Fang L; Bogert CL; Weber SJ; Hunt M; Davis TP; Wamsley JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1077-83. PubMed ID: 1653834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.